Although EB1089 is 50–200 times more potent than vitamin D3 [23], when added to cultured myotubes from a dysferlinopathy patient it only produces a trend towards an increase in dysferlin expression. The gene discussed is DYSF; the disease is neuromuscular disease caused by qualitative or quantitative defects of dysferlin.